The impact of infectious diseases, exacerbated by COVID-19, continues to be overshadowed by rising chronic diseases, particularly in low-income countries due to corporate influence.
Despite the threats from diseases like mpox, the inequitable distribution of healthcare resources highlights a persistent negligence towards Africa's health, driven by profit motives.
Chronic conditions such as diabetes and heart disease account for three-quarters of global deaths, leading to an urgent need to address their rising prevalence.
The WHO's recognition of commercial determinants of health reflects a growing awareness of how corporate behaviors exacerbate health disparities, particularly in poorer nations.
Collection
[
|
...
]